Lateral flow test engineering and lessons learned from COVID-19

[1]  I. Eckerle,et al.  Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant , 2022, Microbiology spectrum.

[2]  Molly M. Stevens,et al.  Nanozyme-catalysed CRISPR assay for preamplification-free detection of non-coding RNAs , 2022, Nature Nanotechnology.

[3]  Straightforward, inexpensive and sensitive , 2022, Nature Biomedical Engineering.

[4]  Kaixiang Zhang,et al.  A paper-based assay for the colorimetric detection of SARS-CoV-2 variants at single-nucleotide resolution , 2022, Nature Biomedical Engineering.

[5]  A. Bharath,et al.  Machine learning to support visual auditing of home-based lateral flow immunoassay self-test results for SARS-CoV-2 antibodies , 2022, Communications Medicine.

[6]  R. Pecori,et al.  Rapid, adaptable and sensitive Cas13-based COVID-19 diagnostics using ADESSO , 2022, Nature Communications.

[7]  R. Peeling,et al.  Evaluation of Zika rapid tests as aids for clinical diagnosis and epidemic preparedness , 2022, EClinicalMedicine.

[8]  Tinna-Solveig F. Kosoko-Thoroddsen,et al.  Simplified Cas13-based assays for the fast identification of SARS-CoV-2 and its variants , 2022, Nature Biomedical Engineering.

[9]  Carrie Arnold.  Home testing for syphilis gains support in wake of COVID , 2022, Nature.

[10]  R. Paredes,et al.  Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern , 2022, Frontiers in Microbiology.

[11]  A. Mann,et al.  Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults , 2022, Nature Medicine.

[12]  Sonjelle Shilton,et al.  Values and preferences of the general population in Indonesia in relation to rapid COVID‐19 antigen self‐tests: A cross‐sectional survey , 2022, Tropical medicine & international health : TM & IH.

[13]  Rethinking diagnostics for pandemic readiness , 2022, Nature Biomedical Engineering.

[14]  Michael R. Thomas,et al.  Sub-picomolar lateral flow antigen detection with two-wavelength imaging of composite nanoparticles. , 2022, Biosensors & bioelectronics.

[15]  Marta Fernandez-Suarez,et al.  COVID-19 diagnostics: preserving manufacturing capacity for future pandemics , 2022, BMJ Global Health.

[16]  Sanjida Karim,et al.  Monitored Implementation of COVID-19 Rapid Antigen Screening at Taxi Ranks in Johannesburg, South Africa , 2022, Diagnostics.

[17]  M. Eisenstein.  Seven technologies to watch in 2022 , 2022, Nature.

[18]  S. Jespersen,et al.  Diagnostic performance, user acceptability, and safety of unsupervised SARS-CoV-2 rapid antigen-detecting tests performed at home , 2021, International Journal of Infectious Diseases.

[19]  S. Hamdan,et al.  Bio-SCAN: A CRISPR/dCas9-Based Lateral Flow Assay for Rapid, Specific, and Sensitive Detection of SARS-CoV-2 , 2021, ACS synthetic biology.

[20]  S. Tonen-Wolyec,et al.  Evaluation of the Practicability of Biosynex Antigen Self-Test COVID-19 AG+ for the Detection of SARS-CoV-2 Nucleocapsid Protein from Self-Collected Nasal Mid-Turbinate Secretions in the General Public in France , 2021, Diagnostics.

[21]  R. Body,et al.  COVID-19 rapid diagnostics: practice review , 2021, Emergency Medicine Journal.

[22]  H. Harrison,et al.  Real-world deployment of lateral flow SARS-CoV-2 antigen detection in the emergency department to provide rapid, accurate and safe diagnosis of COVID-19 , 2021, Infection Prevention in Practice.

[23]  He Gao,et al.  Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key Workers , 2021, Open forum infectious diseases.

[24]  C. D. Geddes,et al.  Sample Preparation and Diagnostic Methods for a Variety of Settings: A Comprehensive Review , 2021, Molecules.

[25]  E. Ivanova Reipold,et al.  Protocol to assess the values and preferences towards SARS-CoV-2 self-testing among the general population and their representatives, healthcare personnel and decision-makers in health: a multi-country mixed methods study. , 2021, JMIR research protocols.

[26]  Aleksandr E. Miklos,et al.  Blind Spot: A Braille Patterned Novel Multiplex Lateral Flow Immunoassay Sensor Array for the Detection of Biothreat Agents , 2021, ACS omega.

[27]  M. Siedner,et al.  Implementation of HIV Self-Testing to Reach Men in Rural uMkhanyakude, KwaZulu-Natal, South Africa. a DO-ART Trial Sub Study , 2021, Frontiers in Public Health.

[28]  Nicolaas M. Angenent-Mari,et al.  Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants , 2021, Science Advances.

[29]  L. Hocqueloux,et al.  Evaluation of a SARS‐CoV‐2 antigen‐detecting rapid diagnostic test as a self‐test: Diagnostic performance and usability , 2021, Journal of Medical Virology.

[30]  J. Collins,et al.  CRISPR-based diagnostics , 2021, Nature Biomedical Engineering.

[31]  Nicolaas M. Angenent-Mari,et al.  Wearable materials with embedded synthetic biology sensors for biomolecule detection , 2021, Nature Biotechnology.

[32]  D. Pillay,et al.  Deep learning of HIV field-based rapid tests , 2021, Nature Medicine.

[33]  Harry D. Nuttall,et al.  COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing , 2021, EClinicalMedicine.

[34]  C. Denkinger,et al.  Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test , 2021, Journal of Clinical Virology.

[35]  J. Lazarus,et al.  Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home , 2021, Scientific Reports.

[36]  I. Buchan,et al.  Rapid antigen testing in COVID-19 responses , 2021, Science.

[37]  Shwetak N. Patel,et al.  The Design and Evaluation of a Mobile System for Rapid Diagnostic Test Interpretation , 2021, Proc. ACM Interact. Mob. Wearable Ubiquitous Technol..

[38]  R. Perera,et al.  Perceptions on undertaking regular asymptomatic self-testing for COVID-19 using lateral flow tests: a qualitative study of university students and staff , 2021, BMJ Open.

[39]  I. Buchan,et al.  Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study , 2021, BMJ.

[40]  N. Sam-Agudu,et al.  COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa , 2021, Globalization and Health.

[41]  Zhenpeng Qin,et al.  Ultrasensitive and Highly Specific Lateral Flow Assays for Point-of-Care Diagnosis. , 2021, ACS nano.

[42]  M. García-Fiñana,et al.  Evaluating social and spatial inequalities of large scale rapid lateral flow SARS-CoV-2 antigen testing in COVID-19 management: An observational study of Liverpool, UK (November 2020 to January 2021) , 2021, The Lancet Regional Health - Europe.

[43]  H. Gendelman,et al.  Diagnostics for SARS-CoV-2 infections , 2021, Nature Materials.

[44]  M. Dong,et al.  CRISPR-based detection of SARS-CoV-2: A review from sample to result , 2021, Biosensors and Bioelectronics.

[45]  P. Goggolidou,et al.  Self-Testing as an Invaluable Tool in Fighting the COVID-19 Pandemic , 2021, Journal of primary care & community health.

[46]  Michael V. D’Ambrosio,et al.  Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy , 2020, Cell.

[47]  P. Flowers,et al.  How can we make self-sampling packs for sexually transmitted infections and bloodborne viruses more inclusive? A qualitative study with people with mild learning disabilities and low health literacy , 2020, Sexually Transmitted Infections.

[48]  Q. Wei,et al.  Addressable nanoantennas with cleared hotspots for single-molecule detection on a portable smartphone microscope , 2020, Nature Communications.

[49]  Debin Zhu,et al.  Simultaneous dual-gene diagnosis of SARS-CoV-2 based on CRISPR/Cas9-mediated lateral flow assay. , 2020, Angewandte Chemie.

[50]  Tinna-Solveig F. Kosoko-Thoroddsen,et al.  Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2 , 2020, Nature Communications.

[51]  D. Larremore,et al.  Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening , 2020, Science Advances.

[52]  J. Morton,et al.  Spin-enhanced nanodiamond biosensing for ultrasensitive diagnostics , 2020, Nature.

[53]  Claudio Parolo,et al.  Tutorial: design and fabrication of nanoparticle-based lateral-flow immunoassays , 2020, Nature Protocols.

[54]  A. van Belkum,et al.  Considerations for diagnostic COVID-19 tests , 2020, Nature Reviews Microbiology.

[55]  A. Plückthun,et al.  Animal-free alternatives and the antibody iceberg , 2020, Nature Biotechnology.

[56]  Nicolaas M. Angenent-Mari,et al.  Ultrasensitive CRISPR-based diagnostic for field-applicable detection of Plasmodium species in symptomatic and asymptomatic malaria , 2020, Proceedings of the National Academy of Sciences.

[57]  J. Joung,et al.  Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA , 2020, Nature Biomedical Engineering.

[58]  Ingemar J. Cox,et al.  Digital technologies in the public-health response to COVID-19 , 2020, Nature Medicine.

[59]  Min-Gon Kim,et al.  Paper/Soluble Polymer Hybrid-Based Lateral Flow Biosensing Platform for High-Performance Point-of-Care Testing. , 2020, ACS applied materials & interfaces.

[60]  Lingwen Zeng,et al.  An ultrasensitive and specific point-of-care CRISPR/Cas12 based lateral flow biosensor for the rapid detection of nucleic acids. , 2020, Biosensors & bioelectronics.

[61]  R. Salunke,et al.  iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2 , 2020, Virus Research.

[62]  A. Holmes,et al.  Antimicrobial use, drug-resistant infections and COVID-19 , 2020, Nature Reviews Microbiology.

[63]  Zachary S. Ballard,et al.  Deep learning-enabled point-of-care sensing using multiplexed paper-based sensors , 2020, npj Digital Medicine.

[64]  Wei Gu,et al.  CRISPR–Cas12-based detection of SARS-CoV-2 , 2020, Nature Biotechnology.

[65]  Jacqueline A. Valeri,et al.  A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection , 2020, Nature Biomedical Engineering.

[66]  R. Peeling,et al.  Call to action for health systems integration of point-of-care testing to mitigate the transmission and burden of sexually transmitted infections , 2020, Sexually Transmitted Infections.

[67]  J. Nkengasong.  Let Africa into the market for COVID-19 diagnostics , 2020, Nature.

[68]  Jian Sun,et al.  Clustered Regularly Interspaced Short Palindromic Repeats/Cas9-Mediated Lateral Flow Nucleic Acid Assay. , 2020, ACS nano.

[69]  Jackie Y. Ying,et al.  Strategies for developing sensitive and specific nanoparticle-based lateral flow assays as point-of-care diagnostic device , 2020 .

[70]  Mads S. Bergholt,et al.  Surface enhanced Raman scattering artificial nose for high dimensionality fingerprinting , 2020, Nature Communications.

[71]  Zachary S. Ballard,et al.  Point-of-Care Serodiagnostic Test for Early-Stage Lyme Disease Using a Multiplexed Paper-Based Immunoassay and Machine Learning. , 2019, ACS nano.

[72]  Min-Gon Kim,et al.  An Automated, Universal, and Mass-Producible Paper-Based Lateral Flow Biosensing Platform for High-Performance Point-of-Care Testing. , 2019, ACS applied materials & interfaces.

[73]  G. Kang,et al.  A new twenty-first century science for effective epidemic response , 2019, Nature.

[74]  Alexandr E Urusov,et al.  Towards Lateral Flow Quantitative Assays: Detection Approaches , 2019, Biosensors.

[75]  N. Khlebtsov,et al.  Quantifying the Numbers of Gold Nanoparticles in the Test Zone of Lateral Flow Immunoassay Strips , 2019, ACS Applied Nano Materials.

[76]  P. V. van Rheenen,et al.  Head-to-head comparison of three stool calprotectin tests for home use , 2019, PloS one.

[77]  Zhaohui Li,et al.  Quantum Dot-Based Lateral Flow Test Strips for Highly Sensitive Detection of the Tetanus Antibody , 2019, ACS Omega.

[78]  E. Corbett,et al.  The Self‐Testing AfRica (STAR) Initiative: accelerating global access and scale‐up of HIV self‐testing , 2019, Journal of the International AIDS Society.

[79]  Michael R. Thomas,et al.  Taking connected mobile-health diagnostics of infectious diseases to the field , 2019, Nature.

[80]  Sebastian Schlücker,et al.  Rapid, Quantitative, and Ultrasensitive Point‐of‐Care Testing: A Portable SERS Reader for Lateral Flow Assays in Clinical Chemistry , 2018, Angewandte Chemie.

[81]  Q. Wei,et al.  Smartphone‐based clinical diagnostics: towards democratization of evidence‐based health care , 2018, Journal of internal medicine.

[82]  Debrah I. Boeras,et al.  REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes , 2018, Nature Microbiology.

[83]  Tsung-Ting Tsai,et al.  Development a stacking pad design for enhancing the sensitivity of lateral flow immunoassay , 2018, Scientific Reports.

[84]  Bernhard H Weigl,et al.  Improving Lateral Flow Assay Performance Using Computational Modeling. , 2018, Annual review of analytical chemistry.

[85]  Hayden C. Metsky,et al.  Field-deployable viral diagnostics using CRISPR-Cas13 , 2018, Science.

[86]  Jennifer A. Doudna,et al.  CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity , 2018, Science.

[87]  James J. Collins,et al.  Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6 , 2018, Science.

[88]  Molly M Stevens,et al.  Platinum Nanocatalyst Amplification: Redefining the Gold Standard for Lateral Flow Immunoassays with Ultrabroad Dynamic Range , 2017, ACS nano.

[89]  John C. Bischof,et al.  The Role of Nanoparticle Design in Determining Analytical Performance of Lateral Flow Immunoassays. , 2017, Nano letters.

[90]  J. O’Grady,et al.  Diagnosing antimicrobial resistance , 2017, Nature Reviews Microbiology.

[91]  Julien Reboud,et al.  Monitoring Genetic Population Biomarkers for Wastewater-Based Epidemiology. , 2017, Analytical chemistry.

[92]  Jennifer C. Brookes,et al.  Unravelling the Molecular Basis of High Affinity Nanobodies against HIV p24: In Vitro Functional, Structural, and in Silico Insights. , 2017, ACS infectious diseases.

[93]  Derek Tseng,et al.  Plasmonics Enhanced Smartphone Fluorescence Microscopy , 2017, Scientific Reports.

[94]  Seung Jun Oh,et al.  An integrated rotary microfluidic system with DNA extraction, loop-mediated isothermal amplification, and lateral flow strip based detection for point-of-care pathogen diagnostics. , 2017, Biosensors & bioelectronics.

[95]  Aviv Regev,et al.  Nucleic acid detection with CRISPR-Cas13a/C2c2 , 2017, Science.

[96]  Xiaojun Ji,et al.  Contactless Measurement of Magnetic Nanoparticles on Lateral Flow Strips Using Tunneling Magnetoresistance (TMR) Sensors in Differential Configuration , 2016, Sensors.

[97]  Peter Chiodini,et al.  Thermal Contrast Amplification Reader Yielding 8-Fold Analytical Improvement for Disease Detection with Lateral Flow Assays. , 2016, Analytical chemistry.

[98]  Guillaume Lambert,et al.  Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components , 2016, Cell.

[99]  M. Rodríguez,et al.  Silver and gold enhancement methods for lateral flow immunoassays. , 2016, Talanta.

[100]  Aydogan Ozcan,et al.  Emerging Technologies for Next-Generation Point-of-Care Testing. , 2015, Trends in biotechnology.

[101]  Aydogan Ozcan,et al.  Cellphone-based devices for bioanalytical sciences , 2014, Analytical and Bioanalytical Chemistry.

[102]  Claudio Parolo,et al.  Paper-based electroanalytical devices with an integrated, stable reference electrode. , 2013, Lab on a chip.

[103]  Derek Tseng,et al.  Fluorescent imaging of single nanoparticles and viruses on a smart phone. , 2013, ACS nano.

[104]  J. Muyembe,et al.  External Quality Assessment of Reading and Interpretation of Malaria Rapid Diagnostic Tests among 1849 End-Users in the Democratic Republic of the Congo through Short Message Service (SMS) , 2013, PloS one.

[105]  C. Schrader,et al.  PCR inhibitors – occurrence, properties and removal , 2012, Journal of applied microbiology.

[106]  Heyou Han,et al.  A fast and sensitive immunoassay of avian influenza virus based on label-free quantum dot probe and lateral flow test strip. , 2012, Talanta.

[107]  Paul Yager,et al.  Multiplexed enrichment and detection of malarial biomarkers using a stimuli-responsive iron oxide and gold nanoparticle reagent system. , 2012, ACS nano.

[108]  Aydogan Ozcan,et al.  Integrated rapid-diagnostic-test reader platform on a cellphone. , 2012, Lab on a chip.

[109]  Paul Yager,et al.  Transport in two-dimensional paper networks , 2011, Microfluidics and nanofluidics.

[110]  Raphael C. Wong,et al.  Lateral flow immunoassay , 2009 .

[111]  Suxian Huang,et al.  Ultrasensitive fluorescence detection of single protein molecules manipulated electrically on Au nanowire. , 2008, Nano letters.

[112]  P. Jain,et al.  Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. , 2007, Nanomedicine.

[113]  C. Plotz,et al.  The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. , 1956, The American journal of medicine.